Partnership Survey Redux: Who will be GTC’s US ATryn partner?
A prior survey on this topic was conducted in November (#msg-24846668), but the highly fragmented voting rendered the tally not especially illuminating, IMO.
Hence, I am trying the survey again with a twist: the answer choices this time are groups of companies. Here we go…
Q: Who will be GTC’s U.S. ATryn partner?
a) GENZ (this is not in a group because it was a popular answer in the prior survey all by itself)
b) One of the traditional Big Pharma (PFE, NVS, GSK, MRK, etc.)
c) One of the traditional Big Biotech (AMGN, DNA, BIIB, etc.)
c) A specialty seller of drugs for the hospital setting (HSP, BAX, Talecris, etc.)